Syndax Pharmaceuticals Obtains $23,961,064 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ce961ddf-31b2-405b-a093-f1ee8f55cec0
Date
6/16/2015
Company Name
Syndax Pharmaceuticals
Mailing Address
400 Totten Pond Road Waltham, MA 02451 USA
Company Description
Syndax Pharmaceuticals, Inc. is a Waltham, MA-based, oncology-focused biotechnology company that is building a portfolio of new oncology products to extend and improve the lives of patients by developing and commercializing novel cancer therapies in optimized, mechanistically driven combination regimens.
Website
http://www.syndax.com
Transaction Type
Venture Equity
Transaction Amount
$23,961,064
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor